Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness

INTRODUCTION: High levels of amyloid β (Aβ) are associated with cognitive decline in cognitively normal (CN) older adults. This study investigated the nature of cognitive decline in healthy individuals who did not progress to mild cognitive impairment or dementia. METHOD: Cognition was measured over...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrington, Karra D., Lim, Yen Ying, Ames, David, Hassenstab, Jason, Laws, Simon M., Martins, Ralph N., Rainey-Smith, Stephanie, Robertson, Joanne, Rowe, Christopher C., Salvado, Olivier, Doré, Vincent, Villemagne, Victor L., Snyder, Peter J., Masters, Colin L., Maruff, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Cognitive & Behavioral Assessment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520957/
https://www.ncbi.nlm.nih.gov/pubmed/28761926
http://dx.doi.org/10.1016/j.dadm.2017.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520957/
https://www.ncbi.nlm.nih.gov/pubmed/28761926
http://dx.doi.org/10.1016/j.dadm.2017.05.006

Ejemplares similares